摘要:

&NA;As the understanding of diabetes continues to improve and treatment methods expand, the clinician can now offer patients with diabetes a greater chance of improved health with fewer complications from diabetes. Aggressive, early treatment of type 2 diabetes, with the goal of achieving a maximum HbA1cof 8% and an ideal of less than 7%, is both health‐enhancing and cost‐effective. Nonpharmacologic treatments, such as nutrition therapy, exercise, weight loss, and self‐management education programs are the most important aspects of care. Pharmacologic therapy should be based on a number of factors and should be individualized for each patient. Treatment options in diabetes will continue to expand as new medications become available and further refinements in treatment decisions occur.

ISSN:0361-1817    

出版商:OVID    

年代:1999

数据来源: OVID

摘要:

&NA;The use of herbal or alternative therapies continues to increase each year. This article extensively reviews four of the more commonly used herbs and dietary supplements: ginkgo biloba, St. John's wort, saw palmetto, and soy. The pharmacology, precautions, therapeutic uses, and adverse effects for each of these therapies are discussed.

ISSN:0361-1817    

出版商:OVID    

年代:1999

数据来源: OVID

ISSN:0361-1817    

出版商:OVID    

年代:1999

数据来源: OVID

摘要:

&NA;Although corneal abrasions are commonly seen in primary care settings, the primary care literature contains scant references on detecting and managing this problem. This article provides an overview of corneal abrasion assessment and treatment. Four common etiologies of abrasion are discussed: traumatic abrasion, contact lens abrasion, foreign body abrasion, and recurrent erosion. Parameters for the history and physical examination are outlined, including sections on contact lens removal, lid eversion, and fluorescein staining. Treatment regimens for each of the etiologies are discussed, with a focus on current research on using pressure eye patches as an intervention. Indications for referral to an ophthalmologist are noted.

ISSN:0361-1817    

出版商:OVID    

年代:1999

数据来源: OVID

ISSN:0361-1817    

出版商:OVID    

年代:1999

数据来源: OVID

ISSN:0361-1817    

出版商:OVID    

年代:1999

数据来源: OVID

ISSN:0361-1817    

出版商:OVID    

年代:1999

数据来源: OVID

ISSN:0361-1817    

出版商:OVID    

年代:1999

数据来源: OVID

ISSN:0361-1817    

出版商:OVID    

年代:1999

数据来源: OVID

ISSN:0361-1817    

出版商:OVID    

年代:1999

数据来源: OVID